These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25025235)

  • 1. The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model.
    Salje H; Andrews JR; Deo S; Satyanarayana S; Sun AY; Pai M; Dowdy DW
    PLoS Med; 2014 Jul; 11(7):e1001674. PubMed ID: 25025235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
    Kendall EA; Schumacher SG; Denkinger CM; Dowdy DW
    PLoS Med; 2017 Dec; 14(12):e1002472. PubMed ID: 29240766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of improvements in diagnosis and treatment accessibility for tuberculosis control in India.
    Suen SC; Bendavid E; Goldhaber-Fiebert JD
    Int J Tuberc Lung Dis; 2015 Sep; 19(9):1115-24, i-xv. PubMed ID: 26260835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study.
    Romanowski K; Campbell JR; Oxlade O; Fregonese F; Menzies D; Johnston JC
    PLoS One; 2019; 14(1):e0211355. PubMed ID: 30677101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Xpert MTB/RIF for TB diagnosis in the private sector: evidence from large-scale pilots in Patna and Mumbai, India.
    Deo S; Jindal P; Papineni S
    BMC Infect Dis; 2021 Jan; 21(1):123. PubMed ID: 33509114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.
    Naidoo P; van Niekerk M; du Toit E; Beyers N; Leon N
    BMC Health Serv Res; 2015 Oct; 15():488. PubMed ID: 26511931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis.
    Sachdeva KS; Raizada N; Gupta RS; Nair SA; Denkinger C; Paramasivan CN; Kulsange S; Thakur R; Dewan P; Boehme C; Arinaminpathy N
    PLoS One; 2015; 10(7):e0131438. PubMed ID: 26132584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
    Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
    Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.
    McDowell A; Raizada N; Khaparde SD; Rao R; Sarin S; Kalra A; Salhotra VS; Nair SA; Boehme C; Denkinger CM
    PLoS One; 2018; 13(3):e0193656. PubMed ID: 29547642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa.
    Dowdy DW; Davis JL; den Boon S; Walter ND; Katamba A; Cattamanchi A
    PLoS One; 2013; 8(8):e70485. PubMed ID: 23950942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant Tuberculosis.
    Padayatchi N; Naidu N; Yende-Zuma N; OʼDonnell MR; Naidoo K; Augustine S; Zumla A; Loveday M
    J Acquir Immune Defic Syndr; 2016 Sep; 73(1):e1-7. PubMed ID: 27509173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of rifampin-resistant tuberculosis in mountainous districts of India.
    Dorjee K; Sadutshang TD; Rana RS; Topgyal S; Phunkyi D; Choetso T; Chodon T; Parmar M; Singla R; Paster Z; Chaisson RE; Kaushal KC
    Indian J Tuberc; 2020 Jan; 67(1):59-64. PubMed ID: 32192619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
    BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of scaling up Xpert
    Awan WM; Zaidi SMA; Habib SS; Khowaja S; Malik A; Khan U; Ferrand RA; Creswell J; Khan A
    Int J Tuberc Lung Dis; 2018 Aug; 22(8):899-904. PubMed ID: 29991399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in distribution and use of tuberculosis diagnostic tests in Kenya: a cross-sectional survey.
    Oliwa JN; Maina J; Ayieko P; Gathara D; Kathure IA; Masini E; Van't Hoog AH; van Hensbroek MB; English M
    BMC Infect Dis; 2018 Jul; 18(1):328. PubMed ID: 30012092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals.
    Diel R; Nienhaus A; Hillemann D; Richter E
    Eur Respir J; 2016 Feb; 47(2):575-87. PubMed ID: 26647440
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.